Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was ...

In the throes of a "bearish-to-bullish" reversal, the stock exhibits bullish price-volume correlation and impressive relative strength to the market and to other biotechnology stocks. We're buyers ...

MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its ...

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.

These biotech companies have catalysts ahead.

・Puma Biotechnology (PBYI) relies on one product. It has weak fundamentals and has struggled to grow sales. ・PBYI stock has surged 91% over the past year, driven by technical momentum and speculative ...

Biotech-focused investor Cormorant Asset Management rebuilt its stake above 6% on Tuesday. ・Cormorant disclosed ownership of ...

One biotech firm raised more than $100 million and another generated more than $200 million in separate stock sales after their valuations soared on positive news for their lead drug candidates.

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

Journey Medical dermatology revenue plus Emrosi near-term sales and a rare pediatric disease PRV from Zycubo approval. See ...